Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 41% ± 25% | |
| oligodendrocyte precursor cell | 9 studies | 34% ± 12% | |
| retinal ganglion cell | 5 studies | 39% ± 12% | |
| GABAergic neuron | 5 studies | 59% ± 15% | |
| amacrine cell | 4 studies | 36% ± 10% | |
| interneuron | 4 studies | 55% ± 24% | |
| type B pancreatic cell | 3 studies | 40% ± 13% | |
| GABAergic interneuron | 3 studies | 26% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 32% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 2925.22 | 2534 / 2642 | 96% | 32.16 | 676 / 705 |
| ovary | 99% | 5347.24 | 178 / 180 | 91% | 25.42 | 392 / 430 |
| pancreas | 81% | 676.51 | 266 / 328 | 71% | 12.38 | 126 / 178 |
| prostate | 76% | 764.98 | 185 / 245 | 75% | 8.29 | 376 / 502 |
| adrenal gland | 53% | 600.47 | 137 / 258 | 68% | 25.16 | 156 / 230 |
| breast | 38% | 253.03 | 173 / 459 | 83% | 28.30 | 930 / 1118 |
| esophagus | 57% | 2064.53 | 830 / 1445 | 54% | 19.00 | 99 / 183 |
| kidney | 90% | 976.47 | 80 / 89 | 18% | 2.44 | 158 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.05 | 1 / 1 |
| stomach | 82% | 901.49 | 293 / 359 | 14% | 2.17 | 40 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 56.00 | 40 / 45 |
| lung | 14% | 69.85 | 83 / 578 | 65% | 18.82 | 746 / 1155 |
| bladder | 38% | 369.76 | 8 / 21 | 39% | 8.12 | 196 / 504 |
| liver | 27% | 172.35 | 60 / 226 | 50% | 11.87 | 202 / 406 |
| uterus | 3% | 49.09 | 5 / 170 | 73% | 33.17 | 336 / 459 |
| heart | 68% | 918.90 | 588 / 861 | 0% | 0 | 0 / 0 |
| thymus | 2% | 10.63 | 13 / 653 | 61% | 9.56 | 368 / 605 |
| skin | 52% | 430.12 | 932 / 1809 | 4% | 0.71 | 21 / 472 |
| muscle | 16% | 123.82 | 126 / 803 | 0% | 0 | 0 / 0 |
| intestine | 6% | 27.84 | 56 / 966 | 9% | 1.71 | 49 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.42 | 2 / 29 |
| peripheral blood | 2% | 7.16 | 15 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.15 | 1 / 80 |
| adipose | 1% | 2.84 | 8 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.86 | 3 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0045087 | Biological process | innate immune response |
| GO_0045957 | Biological process | negative regulation of complement activation, alternative pathway |
| GO_0006958 | Biological process | complement activation, classical pathway |
| GO_0030449 | Biological process | regulation of complement activation |
| GO_0045959 | Biological process | negative regulation of complement activation, classical pathway |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| Gene name | SUSD4 |
| Protein name | Sushi domain-containing protein 4 SUSD4 protein Sushi domain containing 4 |
| Synonyms | UNQ196/PRO222 |
| Description | FUNCTION: Acts as a complement inhibitor by disrupting the formation of the classical C3 convertase. Isoform 3 inhibits the classical complement pathway, while membrane-bound isoform 1 inhibits deposition of C3b via both the classical and alternative complement pathways. . |
| Accessions | A5YM74 ENST00000343846.7 [Q5VX71-1] ENST00000366878.9 [Q5VX71-1] ENST00000344029.6 [Q5VX71-3] V9GYN8 Q5VX71 ENST00000681285.1 ENST00000608996.5 ENST00000679807.1 ENST00000680429.1 V9GZ49 ENST00000679975.1 A0A7P0T864 A0A7P0Z409 A0A7P0T8V7 ENST00000681404.1 ENST00000681305.1 [Q5VX71-1] ENST00000484758.6 ENST00000681669.1 [Q5VX71-1] A0A7P0Z457 ENST00000494793.6 B7Z369 |
